Evidence map›Paper›PMID 23819011›Full record

ReviewOxidative medicine and cellular longevity2013

Mitochondrial signaling: forwards, backwards, and in between.

Sean P Whelan, Brian S Zuckerbraun

Registry-linked trialAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03772964 (A Pilot Study), which is not on this map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03772964 phase1 / phase2completednot on this mapstarted 2019, after this paper: background citation

A Pilot Study: Metformin as an Inflammatory Modulating Therapy in Older Adults Without Diabetes

TypeinterventionalSponsorBrian ZuckerbraunRan2019 to 2020Enrolled32ConditionsInflammatory ResponseArmsMetFORMIN Hydrochloride ER, Placebo
3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Review
  3. Mitochondria-Nuclear Crosstalk: Orchestrating mtDNA Maintenance.Environmental and molecular mutagenesis · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Oxidative Stress and the Neurovascular Unit.Life (Basel, Switzerland) · 2021
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sean P WhelanDepartment of General Surgery, University of Pittsburgh and VA Pittsburgh Healthcare System, Pittsburgh, PA 15206, USA.
Brian S Zuckerbraun

Funding

Heme Oxygenase Enzymes/Carbon Monoxide in Hepatic Dysfunction from hemorrhageR01GM082830 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZUCKERBRAUN, BRIAN SCOTT · 2010 to 2014
$1.5M
NIGMS NIH HHS R01 GM082830
6 · The paper itself

Abstract

Mitochondria are semiautonomous organelles that are a defining characteristic of almost all eukaryotic cells. They are vital for energy production, but increasing evidence shows that they play important roles in a wide range of cellular signaling and homeostasis. Our understanding of nuclear control of mitochondrial function has expanded over the past half century with the discovery of multiple transcription factors and cofactors governing mitochondrial biogenesis. More recently, nuclear changes in response to mitochondrial messaging have led to characterization of retrograde mitochondrial signaling, in which mitochondria have the ability to alter nuclear gene expression. Mitochondria are also integral to other components of stress response or quality control including ROS signaling, unfolded protein response, mitochondrial autophagy, and biogenesis. These avenues of mitochondrial signaling are discussed in this review.

Indexed as

Signal TransductionAnimalsCell NucleusHumansMitochondriaModels, BiologicalStress, Physiological

Identifiers

PMID23819011
PMCPMC3681274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.